Skip to content

Clinical trials

Terminated Autism Spectrum Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Status: Terminated Country / region: United States Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20102
20113
20123
20133
20143
20153
20163
20174
20185
20197
20203
20211
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)4
Hoffmann-La Roche3
Massachusetts General Hospital3
Seaside Therapeutics, Inc.2
Stanford University2
University of Arkansas2
University of Nebraska2
Yale University2
Arizona State University1
Boston University Charles River Campus1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder47
Autistic Disorder20
Child Development Disorders, Pervasive4
Asperger Syndrome3
Attention Deficit Disorder with Hyperactivity3
Bipolar Disorder2
Sleep Wake Disorders2
Acquired Immunodeficiency Syndrome1
Anemia, Sickle Cell1
Anxiety Disorders1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.